174 related articles for article (PubMed ID: 27388945)
1. Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential.
Jablonowski LJ; Alfego D; Andorko JI; Eisenbrey JR; Teraphongphom N; Wheatley MA
Biomaterials; 2016 Oct; 103():197-206. PubMed ID: 27388945
[TBL] [Abstract][Full Text] [Related]
2. Drug Delivery from a Multi-faceted Ultrasound Contrast Agent: Influence of Shell Composition.
Jablonowski LJ; Teraphongphom NT; Wheatley MA
Mol Pharm; 2017 Oct; 14(10):3448-3456. PubMed ID: 28814080
[TBL] [Abstract][Full Text] [Related]
3. Shell effects on acoustic performance of a drug-delivery system activated by ultrasound.
Jablonowski LJ; Cochran MC; Eisenbrey JR; Teraphongphom NT; Wheatley MA
J Biomed Mater Res A; 2017 Nov; 105(11):3189-3196. PubMed ID: 28771937
[TBL] [Abstract][Full Text] [Related]
4. Formation of Microbubbles for Targeted Ultrasound Contrast Imaging: Practical Translation Considerations.
Unnikrishnan S; Du Z; Diakova GB; Klibanov AL
Langmuir; 2019 Aug; 35(31):10034-10041. PubMed ID: 30509068
[TBL] [Abstract][Full Text] [Related]
5. Influence of shell composition on the resonance frequency of microbubble contrast agents.
Dicker S; Mleczko M; Siepmann M; Wallace N; Sunny Y; Bawiec CR; Schmitz G; Lewin P; Wrenn SP
Ultrasound Med Biol; 2013 Jul; 39(7):1292-302. PubMed ID: 23683409
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the effects of microbubble shell disruption on population scattering and implications for modeling contrast agent behavior.
Chien CT; Burns PN
IEEE Trans Ultrason Ferroelectr Freq Control; 2004 Mar; 51(3):286-92. PubMed ID: 15128215
[TBL] [Abstract][Full Text] [Related]
7. Trans-Stent B-Mode Ultrasound and Passive Cavitation Imaging.
Haworth KJ; Raymond JL; Radhakrishnan K; Moody MR; Huang SL; Peng T; Shekhar H; Klegerman ME; Kim H; McPherson DD; Holland CK
Ultrasound Med Biol; 2016 Feb; 42(2):518-27. PubMed ID: 26547633
[TBL] [Abstract][Full Text] [Related]
8. Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy.
Stride EP; Coussios CC
Proc Inst Mech Eng H; 2010; 224(2):171-91. PubMed ID: 20349814
[TBL] [Abstract][Full Text] [Related]
9. [Aolymer-encapsulated microbubble contrast agent: preparation and in vitro echogenic characteristics].
Jin QF; Zhong Y; Luo XL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):54-6. PubMed ID: 18227027
[TBL] [Abstract][Full Text] [Related]
10. Effects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brain.
Wu SY; Chen CC; Tung YS; Olumolade OO; Konofagou EE
J Control Release; 2015 Aug; 212():30-40. PubMed ID: 26065734
[TBL] [Abstract][Full Text] [Related]
11. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
[TBL] [Abstract][Full Text] [Related]
12. Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization.
Perera RH; Wu H; Peiris P; Hernandez C; Burke A; Zhang H; Exner AA
Nanomedicine; 2017 Jan; 13(1):59-67. PubMed ID: 27565686
[TBL] [Abstract][Full Text] [Related]
13. Influence of nesting shell size on brightness longevity and resistance to ultrasound-induced dissolution during enhanced B-mode contrast imaging.
Wallace N; Dicker S; Lewin P; Wrenn SP
Ultrasonics; 2014 Dec; 54(8):2099-108. PubMed ID: 25041980
[TBL] [Abstract][Full Text] [Related]
14. Ultrafast 2-dimensional image monitoring and array-based passive cavitation detection for ultrasound contrast agent destruction in a variably sized region.
Xu S; Hu H; Jiang H; Xu Z; Wan M
J Ultrasound Med; 2014 Nov; 33(11):1957-70. PubMed ID: 25336483
[TBL] [Abstract][Full Text] [Related]
15. WE-C-218-01: Ultrasound Contrast Agents.
Streeter JE; Dayton PA
Med Phys; 2012 Jun; 39(6Part27):3953. PubMed ID: 28520019
[TBL] [Abstract][Full Text] [Related]
16. Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction.
Borden MA; Kruse DE; Caskey CF; Zhao S; Dayton PA; Ferrara KW
IEEE Trans Ultrason Ferroelectr Freq Control; 2005 Nov; 52(11):1992-2002. PubMed ID: 16422411
[TBL] [Abstract][Full Text] [Related]
17. [Ultrasound contrast agents--physical basics].
Kollmann C; Putzer M
Radiologe; 2005 Jun; 45(6):503-12. PubMed ID: 15809841
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design.
Kang ST; Yeh CK
Chang Gung Med J; 2012; 35(2):125-39. PubMed ID: 22537927
[TBL] [Abstract][Full Text] [Related]
19. Nano-lipospheres as acoustically active ultrasound contrast agents: evolving tumor imaging and therapy technique.
Andrews LE; Chan MH; Liu RS
Nanotechnology; 2019 May; 30(18):182001. PubMed ID: 30645984
[TBL] [Abstract][Full Text] [Related]
20. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
